Who are Oculis Holding AG's main suppliers?

Oculis Holding AG (OCS) key suppliers include: ACCURE, Novartis AG, Novartis AG, Novartis AG. View the full supplier network at chainsifter.com/chain/OCS.

Who are Oculis Holding AG's major customers?

Oculis Holding AG (OCS) key customers include: Novartis AG, Novartis AG, Alcon Inc., Bank of America Corporation. View the full customer network at chainsifter.com/chain/OCS.

What sector is Oculis Holding AG in?

Oculis Holding AG (OCS) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Oculis Holding AG Suppliers, Customers & Supply Chain (OCS)

4Suppliers

4Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Oculis Holding AG (OCS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

10Total relationships

1Distinct source URLs

5High confidence

0.790Average confidence

2026-10-29Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Oculis Holding AG Suppliers

Ticker	Name	Confidence	Evidence
ACCURE	ACCURE	90%	For example, we are party to various license agreements, including with Accure and Novartis, that we depend on for rights to Privosegtor and Licaminlimab, respectively.
NVS	Novartis AG	90%	For example, we are party to various license agreements, including with Accure and Novartis, that we depend on for rights to Privosegtor and Licaminlimab, respectively.
NVS	Novartis AG	90%	Reciprocal relationship from NVS graph: Reciprocal relationship from OCS graph: For example, we are party to various license agreements, including with Accure and Novartis, that we depend on for righ…
NVSEF	Novartis AG	72%	Reciprocal relationship from NVSEF graph: Reciprocal relationship from OCS graph: Reciprocal relationship from NVSEF graph: Reciprocal relationship from OCS graph: Reciprocal relationship from NVSEF …

Oculis Holding AG Customers

Ticker	Name	Confidence	Evidence
NVSEF	Novartis AG	72%	Reciprocal relationship from NVSEF graph: Reciprocal relationship from OCS graph: Reciprocal relationship from NVSEF graph: Reciprocal relationship from OCS graph: Reciprocal relationship from NVSEF …
NVSEF	Novartis AG	72%	ction with its spin-off from Novartis. 130 We are deemed the owner of any inventions that are (a) created solely by or on behalf of us pursuant to the Novartis Agreement and (b) severable from the li…
ALC	Alcon Inc.	62%	Reciprocal relationship from ALC graph: Reciprocal relationship from OCS graph: Reciprocal relationship from ALC graph: Reciprocal relationship from OCS graph: Reciprocal relationship from ALC graph:…
BAC	Bank of America Corporation	62%	Reciprocal relationship from BAC graph: Reciprocal relationship from OCS graph: Reciprocal relationship from BAC graph: Reciprocal relationship from OCS graph: Reciprocal relationship from BAC graph:…

Oculis Holding AG Debt Obligations

Instrument	Description	Confidence	Evidence
OCS-DEBT	Debt stack $2.9M	90%	Market cache reports total debt of $2.9M.

Oculis Holding AG Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Oculis Holding AG.

Oculis Holding AG Ownership

Holder	Name	Confidence	Evidence
OCS-OWNER-EQT-FUND-MANAGEMENT-S-A-R-L	EQT Fund Management S.a r.l.	90%	13F overlay lists EQT Fund Management S.a r.l. as top holder; 58 tracked holders.

Oculis Holding AG Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
COLL	Collegium Pharmaceutical, Inc.	100.00	2
LQDA	Liquidia Corporation	100.00	2
ELVN	Enliven Therapeutics, Inc.	100.00	2
BAC	Bank of America Corporation	100.00	1	['customer']
HLN	Haleon plc	100.00	2
KLRS	Kalaris Therapeutics, Inc.	100.00	2
SDGR	Schrödinger, Inc.	100.00	2
SLGL	Sol-Gel Technologies Ltd.	100.00	2
ANL	Adlai Nortye Ltd.	100.00	2
ABT	Abbott Laboratories	100.00	2
CTNM	Contineum Therapeutics, Inc.	100.00	2
HLNCF	Haleon plc	100.00	2
BNBX	BNB Plus Corp.	100.00	2
JBIO	Jade Biosciences, Inc.	100.00	2
ALNY	Alnylam Pharmaceuticals, Inc.	100.00	2
ALC	Alcon Inc.	100.00	1	['customer']
BIOA	BioAge Labs, Inc.	100.00	2
CPMV	Mosaic ImmunoEngineering, Inc.	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
OLMA	Olema Pharmaceuticals, Inc.	100.00	2

Oculis Holding AG Supply Chain